Pronađeno: 1-10 / 25 radova

Autori: Andric Zoran G

>> Prikaži sve rezultate

>> Sve godine

Naslov Avelumab Versus Platinum-Based Doublet Chemotherapy as First-Line Treatment for Patients With High-Expression Programmed Death-Ligand 1-Positive Metastatic NSCLC: Primary Analysis From the Phase 3 JAVELIN Lung 100 Trial (Article)
Autori Reck Martin ... Andric Zoran G  ... (broj koautora 18) 
Info JOURNAL OF THORACIC ONCOLOGY, (2024), vol. 19 br. 2, str. 297-313
Projekat Healthcare business of Merck KGaA, Darmstadt, Germany; Pfizer
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati:
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study (Article)
Autori Leal Ticiana A ... Andric Zoran G  ... (broj koautora 25) 
Info LANCET ONCOLOGY, (2023), vol. 24 br. 9, str. 1002-1017
Projekat Novocure
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Candidate Bevacizumab Biosimilar CT-P16 versus European Union Reference Bevacizumab in Patients with Metastatic or Recurrent Non-Small Cell Lung Cancer: A Randomized Controlled Trial (Article)
Autori Verschraegen Claire Andric Zoran G  Moiseenko Fedor Makharadze Tamta Shevnya Sergii Oleksiienko Alona Ruiz Eduardo Yanez Kim SungHyun Ahn KeumYoung Park TaeHong Park Sijin Ju Hana Ohe Yuichiro 
Info BIODRUGS, (2022), vol. 36 br. 6, str. 749-760
Projekat Celltrion, Inc. (Incheon, Republic of Korea)
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Trilaciclib prior to gemcitabine plus carboplatin for metastatic triple-negative breast cancer: phase III PRESERVE 2 (Article)
Autori Goel Shom Tan Antoinette R Rugo Hope S Aftimos Philippe Andric Zoran G  Beelen Andrew Paul Zhang Jingshan Yi John S Malik Rajesh K O'Shaughnessy Joyce 
Info FUTURE ONCOLOGY, (2022), vol. 18 br. 33, str. 3701-3711
Projekat G1 Therapeutics; Eli Lilly; Merck; Pfizer; AstraZeneca; Ayala; Boehringer Ingelheim; Daiichi; Gilead; Lilly; Macrogenics; Novartis; OBI; Odonate; Polyphor; Roche; Seattle Genetics; Sermonix
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Atezolizumab versus chemotherapy in advanced or metastatic NSCLC with high blood-based tumor mutational burden: primary analysis of BFAST cohort C randomized phase 3 trial (Article)
Autori Peters Solange ... Andric Zoran G  ... (broj koautora 26) 
Info NATURE MEDICINE, (2022), vol. 28 br. 9, str. 1831-+
Projekat F. Hoffmann-La Roche, Ltd.
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Overweight and obesity in polycystic ovary syndrome: association with inflammation, oxidative stress and dyslipidaemia (Article)
Autori Perovic-Blagojevic Iva M Vekic Jelena Z  Macut Djuro P  Ignjatovic Svetlana D  Miljkovic-Trailovic Milica M Zeljkovic Aleksandra R  Spasojevic-Kalimanovska Vesna V Bozic-Antic Ivana B Bjekic-Macut Jelica D Kastratovic-Kotlica Biljana A Andric Zoran G  Ilic Dusan S Kotur-Stevuljevic Jelena M 
Info BRITISH JOURNAL OF NUTRITION, (2022), vol. 128 br. 4, str. 604-612
Projekat Serbian Ministry of Science and Education [200110, 451-03-9/2021-14/200161]
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Effects of Trilaciclib on Chemotherapy-Induced Myelosuppression and Patient-Reported Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer: Pooled Results from Three Phase II Randomized, Double-Blind, Placebo-Controlled Studies (Article)
Autori Weiss Jared Goldschmidt Jerome Andric Zoran G  Dragnev Konstantin H Gwaltney Chad Skaltsa Konstantina Pritchett Yili Antal Joyce M Morris Shannon R Daniel Davey 
Info CLINICAL LUNG CANCER, (2021), vol. 22 br. 5, str. 449-460
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1-Selected NSCLC (Article)
Autori Jassem Jacek ... Andric Zoran G  ... (broj koautora 19) 
Info JOURNAL OF THORACIC ONCOLOGY, (2021), vol. 16 br. 11, str. 1872-1882
Projekat Roche HoldingGenentech; F. Hoffmann-La Roche Ltd.Hoffmann-La Roche; Genentech, Inc.Roche HoldingGenentech
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Polycystic Ovary Syndrome: A Contemporary Clinical Approach (Review)
Autori Bjekic-Macut Jelica D Vukasin Tamara Velija-Asimi Zelija Burekovic Azra Zdravkovic Marija D  Andric Zoran G  Brankovic Marija S  Crevar-Marinovic Slobodanka Madic Tatjana Stanojlovic Olivera P  Milutinovic Danijela V Livadas Sarantis Mastorakos George 
Info CURRENT PHARMACEUTICAL DESIGN, (2021), vol. 27 br. 36, str. 3812-3820
Projekat Ministry of Education, Science and Technological Development, Serbia [451-03-68/2020-14/200007]
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Efficacy and Safety of Bevacizumab Biosimilar FKB238 Versus Originator Bevacizumab: Results from AVANA, a Phase III Trial in Patients with Non-Squamous Non-Small-Cell Lung Cancer (non-sq-NSCLC) (Article)
Autori Syrigos Konstantinos Abert Istvan Andric Zoran G  Bondarenko Igor N Dvorkin Mikhail Galic Kristina Galiulin Rinat Kuchava Vladimer Sriuranpong Virote Trukhin Dmytro Zhavrid Edvard Fu Dongyue Kassalow Laurent M Jones Stephanie Bashir Zahid 
Info BIODRUGS, (2021), vol. 35 br. 4, str. 417-428
Projekat Centus Biotherapeutics
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
>> Sve godine

Ispis zapisa u formatu:TXT | BibTeX